Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
Cancer Vaccines01:30

Cancer Vaccines

1.1K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.2K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CD4<sup>+</sup>CD25<sup>+</sup> regulatory T cells circumstantially initiate transplant rejection through CXCL15/neutrophil axis.

Communications biology·2026
Same author

Microparticles synthesized from itaconate polyesters enable metabolite delivery and elicit immunoregulatory outcomes.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

Integrating molecular dynamics simulations to enable rational assembly of immune signals for immunotherapy.

Nanoscale horizons·2026
Same author

PEGylation strategies for enhanced nanoparticle delivery to tumor-associated immune cells.

Bioengineering & translational medicine·2026
Same author

High Humidity Exacerbates Psoriasiform Skin Disease Relapse by Increasing Tissue-Resident Memory T Cells via Altering Skin Microbiota.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Corrigendum to "Defining Relationships Among Tests for Kidney Transplant Antibody-Mediated Rejection" [<i>Kidney International Reports</i> Volume 10, Issue 9, September 2025, Pages 3225-3238].

Kidney international reports·2026

Related Experiment Video

Updated: Feb 16, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.3K

Improving Vaccine and Immunotherapy Design Using Biomaterials.

Michelle L Bookstaver1, Shannon J Tsai1, Jonathan S Bromberg2

  • 1Fischell Department of Bioengineering, University of Maryland, 8228 Paint Branch Drive, College Park, MD 20742, USA.

Trends in Immunology
|December 19, 2017
PubMed
Summary

Biomaterials like polymers and lipids enhance vaccine and immunotherapy effectiveness. Understanding biomaterial-immune interactions aids in designing better treatments for diseases and conditions.

Keywords:
autoimmunity and transplantationbiomaterial and nanotechnologycancerinfectious diseasenanoparticle and microparticlevaccine and immunotherapy

More Related Videos

Intra-lymph Node Injection of Biodegradable Polymer Particles
09:06

Intra-lymph Node Injection of Biodegradable Polymer Particles

Published on: January 2, 2014

15.2K
Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.8K

Related Experiment Videos

Last Updated: Feb 16, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.3K
Intra-lymph Node Injection of Biodegradable Polymer Particles
09:06

Intra-lymph Node Injection of Biodegradable Polymer Particles

Published on: January 2, 2014

15.2K
Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.8K

Area of Science:

  • Biomaterials science and immunology
  • Drug delivery systems
  • Translational medicine

Background:

  • Biomaterials are increasingly used to enhance vaccine and immunotherapy efficacy.
  • Understanding biomaterial-immune system interactions is crucial for optimizing therapeutic design.
  • Applications span infectious diseases, cancer, autoimmunity, and transplantation.

Purpose of the Study:

  • To review recent advances in biomaterial applications for vaccines and immunotherapies.
  • To highlight how biomaterial features improve therapeutic outcomes.
  • To identify key questions for future research in this field.

Main Methods:

  • Literature review of recent studies on biomaterials in vaccines and immunotherapies.
  • Analysis of biomaterial properties and their impact on immune responses.
  • Synthesis of current knowledge and identification of research gaps.

Main Results:

  • Biomaterials such as polymers, lipids, scaffolds, and microneedles show significant promise.
  • Unique biomaterial features can be leveraged to boost immune responses.
  • New insights into material-immune interactions are emerging.

Conclusions:

  • Biomaterials offer powerful strategies for advancing vaccine and immunotherapy development.
  • Further research into biomaterial-immune interactions will drive innovation.
  • Exploiting biomaterial characteristics is key to more effective treatments.